We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) presented positive detailed data from the global pivotal Phase II single-arm DESTINY-Breast01 trial of ...